BrainScanology
An objective diagnosis & risk score for common brain diseases delivered in 24hr
Overview
Raised: $164,965
Total Commitments ($USD)
Wefunder
12/18/2020
08/31/2021
$50,000
$1,070,000
$100
SAFE
Pre-Seed
RegCF
$20,000,000
30%
Rolling Commitments ($USD)
09/05/2021
330%
15%
$644
184
2020
Healthcare & Pharmaceuticals
HealthTech
B2B2C
Medium
Low
Summary Profit and Loss Statement
| Most Recent Year | Prior Year | |
|---|---|---|
|
Revenue |
$0 |
$0 |
|
COGS |
$0 |
$0 |
|
Tax |
$0 |
$0 |
| ||
| ||
|
Net Income |
$0 |
$0 |
Summary Balance Sheet
| Most Recent Year | Prior Year | |
|---|---|---|
|
Cash |
$0 |
$0 |
|
Accounts Receivable |
$0 |
$0 |
|
Total Assets |
$0 |
$0 |
|
Short-Term Debt |
$0 |
$0 |
|
Long-Term Debt |
$0 |
$0 |
|
Total Liabilities |
$0 |
$0 |
Upgrade to gain access
-
$12.42 /month
billed annually - Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings (excluding risk)
- Advanced company search ( with ratings)
- Markets page filters and historical industry data
- Get Edge Annual
Edge
-
$41.58 /month
billed annually - Full site access including KingsCrowd's qualitative analyst reports.
- Plan Includes:
- Everything in Edge, plus
- Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
- Search and filter based on Analyst Reports
- In-depth risk ratings for every raise
- Get Edge Pro Annual
Edge Pro
Buy BrainScanology's Deal Report
Warning: according to the close date for this deal, BrainScanology may no longer be accepting investments.
Get KingsCrowd’s comprehensive report on BrainScanology including:
- How our proprietary algorithm rates their current capital raise (1-5 stars)
- Detailed price, market, team, differentiators, performance, and risk ratings
- Whether BrainScanology is undervalued or overvalued
- Scores on the founding team and key personnel's background and expertise
Buy the BrainScanology deal report for only $10!
Ratings 
